Alphatec Holdings, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
Alphatec Holdings, Inc. announced a 25% increase in total revenue to $764.2 million for the fiscal year ended December 31, 2025, driven by surgeon adoption and product portfolio expansion.
NASDAQ
Alphatec Holdings' 2024 annual report reveals a 27% revenue increase, driven by surgeon adoption of its innovative spine surgery technologies.
NASDAQ
Alphatec Holdings, a medical technology company focused on spine disorders, announced a 37% increase in revenue for the year ended December 31, 2023, reaching $482.3 million.